• Info
  • Insider Ownership

Insider Trading & Ownership of Andrea Ellis

Location
Palo Alto, CA
Summary
The estimated net worth of Andrea Ellis is at least $1,205,833 dollars as of 06 Mar 2026. Andrea Ellis is the Director of BridgeBio Pharma, Inc. and owns shares of BridgeBio Pharma, Inc. (BBIO) stock worth about $1.21M.
Signature
/s/ Will Solis, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Andrea Ellis and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to save research and follow filings

Sponsored

Quick Takeaways

  • Andrea Ellis has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $1,205,833.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: BridgeBio Pharma, Inc. ($1,205,833).
  • Past-year value change for that position: -$5,052,485.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Andrea Ellis

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BBIO BridgeBio Pharma, Inc. Director $1,205,833 -$5,052,485 -81% 04 Mar 2026

Insider Transactions Reported by Andrea Ellis:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored